Biocept Priced, Nasdaq: BIOC
Develops and markets cancer diagnostic tests.
Industry: Health Care
First Day Return: -6.0%
Industry: Health Care
BIOC
Develops and markets cancer diagnostic tests.
| IPO Data | |
|---|---|
| IPO File Date | 09/23/2013 |
| Offer Price | $10.00 |
| Price Range $10.00 - $12.00 | |
| Offer Shares (mm) | 1.9 |
| Deal Size ($mm) | $19 |
| Lock-Up Date | IPO Pro Only |
| Street Research | IPO Pro Only |
| IPO Data | |
|---|---|
| IPO Date | 02/04/2014 |
| Offer Price | IPO Intelligence Only |
| Price Range | IPO Intelligence Only |
| Offer Shares (mm) | IPO Intelligence Only |
| Deal Size ($mm) | $19 |
| Lock-Up Date | IPO Intelligence Only |
| Street Research | IPO Intelligence Only |
| Underwriters |
|---|
| IPO Intelligence Only |
| Company Data | |
|---|---|
| Headquarters | San Diego, CA, United States |
| Founded | 1997 |
| Employees at IPO | 27 |
| Website www.biocept.com | |
IPO News for Biocept
Biocept (BIOC) Performance
